Table 1.

Patient disposition in the axitinib and placebo titration arms

Disposition, n (%)	Axitinib Titration n = 56	Placebo Titration n = 56
Discontinued treatment	47 (84)	55 (98)
Disease progression/relapse	35 (63)	40 (71)
Adverse event	8 (14)	5 (9)
Death	2 (4)	1 (2)
Refusal of treatment for reason other than adverse event	1 (2)	4 (7)
Global deterioration in health status	1 (2)	1 (2)
Protocol violation	0	1 (2)
Other	0	3 (5)
Remaining on treatment	9 (16)	1 (2)